Investment Trusts

Oryx International Growth Fund

GG00B3BTVQ94:GBX

Oryx International Growth Fund

  • Price (GBX)1,208.00
  • Today's Change18.00 / 1.51%
  • Shares traded4.10k
  • 1 Year change6.90%
  • Beta0.8528
Data delayed at least 20 minutes, as of Apr 26 2024 14:28 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceOryx International Growth Fund (Ordinary Share)+2.65%
NAVOryx International Growth Fund (Ordinary Share)+12.23%
Morningstar's BenchmarkFTSE All Share (TR)+6.56%

Announcements

More ▼

Key statistics

As of last trade Oryx International Growth Fund (GG00B3BTVQ94:GBX) traded at 1,208.00, -5.63% below its 52-week high of 1,280.00, set on Nov 28, 2023.
52-week range
Today
1,020.00Nov 10 20231,280.00Nov 28 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding14.00m
Market cap162.40m GBP
Total assets235.06m GBP
Total expense ratio1.37%
High1,160.00
Low1,160.00
Previous close1,190.00
Average volume8.33k
YTD Change+0.25%
Beta0.8528
Diluted NAV (est)1,679.00
Diluted NAV (last pub)1,679.00
Premium/Discount-30.91%
Net Gearing0.00%
Data delayed at least 20 minutes, as of Apr 26 2024 14:28 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.